Old Web
English
Sign In
Acemap
>
Paper
>
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
2020
Carsten Utoft Niemann
Mark-David Levin
Julie Dubois
Sabina Kersting
Lisbeth Enggaard
Gerrit J. Veldhuis
Rogier Mous
Clemens Mellink
Johan A. Dobber
Christian Bjørn Poulsen
Henrik Frederiksen
Ann Janssens
Ida Schjødt
Ellen C. Dompeling
Juha Ranti
Mattias Mattsson
Mar Bellido
Hoa T. T. Tran
Kazem Nasserinejad
Arnon P. Kater
Keywords:
Oncology
Internal medicine
Ibrutinib
relapsed refractory
Chronic lymphocytic leukemia
Venetoclax
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
20
References
6
Citations
NaN
KQI
[]